ヒロポン/HIRO-PON 🐸🖌️
owohiropon.bsky.social
ヒロポン/HIRO-PON 🐸🖌️
@owohiropon.bsky.social
🇲🇽 (30) Vagabond Artist He/Him Esp|Eng|日本 Art: #Hirasuto

Creative at @thedaiblue / ✉️Business: owohiropon@gmail.com
It's just frustrating waking up every morning praying I'll will be able to work and raise the rest of the myself, then just realizing the symptoms worsen each day 🫠💔

I feel so ashamed of myself, I'm really, really sorry...
June 21, 2025 at 6:45 AM
(-) For this reason I'm now far from the rituximab coverage and I wanted to ask for your understanding if I edit the goal, as well as asking you to keep sharing this around.

You've already done so much for me so you don't have to, but this means the world to me rn. 🙇❤️‍🩹
June 18, 2025 at 5:34 AM
(-) The nearest hospital was a private establishment so said stay was extremely expensive. As I've said before, I'll post a croped picture of the bill because it has my exact address and my parents name's but full documents can be discussed in private. (2)
June 18, 2025 at 5:34 AM
Update 2: On sunday, June 1st 2025 I suffered a heart attack consequence of the prolongued systemic inflamation.

I was rushed to the ER and stayed there while my condition stabilized. Unfortunatelly, I wasn't able to take pictures of the electrocardiogram screening. (1)
June 18, 2025 at 5:34 AM
Therefore, I hereby certify the urgent need to continue her treatment. This document is issued for any purposes deemed appropriate by the interested party.]
June 18, 2025 at 5:31 AM
an anti-CD20+ monoclonal antibody, prednisone, and azathioprine. Rituximab therapy must be continued for at least 2 to 3 years, with infusions spaced every 4 to 6 months. This drug is expensive for the patient and her family, who have expressed difficulty in obtaining it. (3)
June 18, 2025 at 5:31 AM
The patient has presented with manifestations of the disease in the central nervous system and upper respiratory tract, as well as severe fatigue and memory and concentration disturbances. Part of her treatment consists of biological drugs such as Rituximab, (2)
June 18, 2025 at 5:31 AM
[Guadalajara, Jalisco, May 29, 2025. To whom it may concern: I hereby certify that (REDACTED), who has been my patient since 2023, has been diagnosed with MPO-positive granulomatosis with polyangiitis. (1)
June 18, 2025 at 5:31 AM
Update:

Certification of diagnosis and treatment. I censored my dead name and sensitive information but if you must, you can request the link for the uncensored documents.

TRANSLATION DOWN BELOW.
June 18, 2025 at 5:30 AM